Muscle Stimulator Market

The Muscle Stimulator Market is valued at USD 823.8 Mn in 2026 and is projected to reach USD 1069.5 Mn, growing at a CAGR of 4% by 2033.

Prevalence of Chronic Pain, and Musculoskeletal Conditions to Boost Muscle Stimulator Market Growth

Rising prevalence of muscle injuries and chronic pain among individuals globally remains instrumental in driving the growth of the muscle stimulator market. For instance, according to the Centers for Disease Control and Prevention (CDC) around 30% of the adult population with an age of 65 years and above worldwide suffer from chronic pain. Around 15% individuals in US in this age range use prescription drugs for pain relief. In addition, rising arthritis prevalence, migraine and back pain is also expected to boost muscle stimulator market growth. For instance, as per WHO (World Health Organization) 2021 report, prevalence of rheumatoid arthritis is increasing and is more common among women and over 23 million individuals suffer from this disease globally. Moreover, as per WHO, around 1.71 individuals suffer from musculoskeletal disorders worldwide resulting in functional limitations, pain, and mobility limitations. These factors continue to influence the adoption of muscle stimulators as they facilitate pain relief and effective rejuvenation. 

Muscle pain is another aspect that is becoming increasingly common among millennials and adults owing to rising participation in physical fitness activities and outdoor sports. Owing to its perceived benefits, muscle stimulators are widely being used by sports enthusiasts to increase strength, facilitate speedy recovery from muscle injuries, gain pain relief, rehabilitation during injuries and for warm up. In this background, the muscle stimulator market is expected to witness momentous growth in the forthcoming years.

TENS to Witness Increasing Demand in Global Muscle Stimulator Market

The demand and sale of transcutaneous electrical nerve stimulator (TENs) is poised to witness a momentous increase in the forthcoming years, thus largely contributing towards the muscle stimulator market growth. The TENS devices are widely used to block or manage pain signals reaching the brain. The transcutaneous electric nerve stimulator is an effective device for treating pain occurring in the lower and upper limbs. Being a non-invasive electrotherapy modality, TENS is gaining high traction and demand worldwide on the back of rising prevalence of chronic pain, muscle related sport injuries and accidents. That said, companies are developing innovative and advanced devices. For instance, in 2021, an announcement was made by NeuroMetrix that its Quell TENS device would undergo clinical trials to gauge the efficacy of transcutaneous electrical nerve stimulator in providing pain relief and if it is an acceptable and feasible device for patients suffering from neuromyelitis optica spectrum disorders (NMOSD). In this backdrop, the scenario for TENS looks promising and is projected to fuel the revenue growth of the muscle stimulator market in the coming years.

North America to Emerge as a Value Growth Contributor for Muscle Stimulator Market

Developed nations in North America have been reflecting high potential apropos to use of muscle stimulators since the past and are expected to maintain status quo in the coming years. This can be attributed towards increasing healthcare expenditure coupled with superior healthcare infrastructure and innovations in the development of novel medical devices. In addition, rise in musculoskeletal disorders is another aspect driving the adoption and use of muscle stimulators in the region. Moreover, during the COVID-19 pandemic, the region was severely impacted.

Government authorities had made efforts to combat the aftereffects of the corona virus in several forms. This also resulted in an increase in the use of respiratory muscle stimulators in the region. For instance, in May 2020, the US FDA gave an Emergency Use Authorization (EUA) to a one-of-its-kind respiratory muscle stimulator – VentFree – developed by Liberate Medical LLC. This was in view of reducing disuse atrophy of the muscles in abdominal walls, in turn decreasing the number of days the patient would need ventilator support, thus reducing the overall vent usage. In this backdrop, the demand for these devices witnessed an upswing in turn contributing towards value growth of muscle stimulator market in the region.

In addition, as per the 2021 report of the Arthritis Society, nearly 20% of the total population or 1 in 5 individuals in Canada suffer from arthritis. Furthermore, pain is one of the most critical reasons pushing individuals in the region to opt for advanced medical aids as it affects a large percentage of population in North America. It is also considered as one of the leading causes of partial or permanent disability thus increasing the economic burden among individuals. Other macro economic factors boosting the growth of the muscle stimulator market in the region include strong economy, stable growth in GDP per capita, inclination towards use of advanced healthcare devices and rising geriatric population. Overall, the scenario for the muscle stimulator market in North America is likely to remain optimistic and manufacturers can expect a myriad of opportunities in the coming years.

New product launches and increasing FDA approvals for these new products has been witnessed in the muscle stimulator market. For instance, in 2020, Lutronic introduced a new gadget called Accufit that offers focused muscle stimulation. In 2021, Cutera Inc. launched the next generation truSculpt flex. The novel truSculpt flex rapid treatment mode took the company’s multi-directional stimulation to a higher level by providing effective firming, toning, and strengthening results in less time. In 2022, the Food and Drug Administration gave clearance and approved Cionic Neural Sleeve for the functional electrical stimulation to assist people with leg muscle weakness. In 2021, the Food and Drug green lighted a wearable electric muscle stimulator to stave off blood pooling and symptoms of critically blocked vessels such as varicose veins in legs by providing a 510(k) clearance. With this clearance Sky Medical was able to initiate a controlled market release of its wearable electric muscle stimulator “Geko” as a first line treatment of ischemia and venous insufficiency.

A few of the major players in global muscle stimulator market include 

• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• Zimmer Biomet Holdings, Inc.
• Bioness Inc.
• DJO Global (Columbia Pacific Medical)
• NeuroMetrix, Inc.
• Empi (DJO Global brand)
• Bioventus LLC
• Chattanooga (DJO Global brand)
• Omron Healthcare
• TENS 7000 (Innovative Health, Inc.)
• Zynex Medical, Inc.
• Richmar (DJO Global brand)
• TheraBand (Hygenic Corp.)

Product Type

• Neuromuscular Electrical Stimulation
• Functional Electrical Stimulation
• Transcutaneous Electrical Nerve Stimulation
• Interferential
• Burst Mode Alternating Current
• Micro Current Electrical Neuromuscular Stimulator
• Others

Modality

• Handheld
• Portable
• Tabletop

Application

• Pain Management
• Neurological Disorder
• Musculoskeletal Disorder
• Others

End-use

• Hospitals
• Ambulatory Surgical Centers
• Physiotherapy Clinics
• Sports Clinics
• Home Care

Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa